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a b s t r a c t
Miller-Fisher syndrome (MFS) is characterized by classical triad of ophthalmoplegia, ataxia
and areﬂexia. The involvement of cerebral white matter in MFS is very rare. We report a
typical MFS patient whose brain MRI showed unilateral and extensive involvement in
cerebral white matter. We also found mild pleocytosis and raised protein concentration
in cerebrospinal ﬂuid. Deﬁcits resolved completely after treatment with intravenous immu-
noglobulins. Subsequent brain MRI shows cavity formation in involved white matter.
# 2015 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Miller-Fisher syndrome (MFS), which is characterized by
ataxia, ophthalmoplegia and areﬂexia, is considered to be a
variant of Guillain-Barré syndrome (GBS) [1]. It is reported that
central nervous system (CNS) could also be involved in MFS [1].
The involvement sites of CNS in MFS are mainly pons, medulla
oblangata [1], cerebellar peduncles [2], and occasionally, optic
nerves [3]. However, the involvement of cerebral white matter
in MFS is very rare. Here, we report a typical MFS patient whose
brain MRI showed unilateral and large lesions in cerebral white
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A 37-year-old man who had no history of toxic substance
exposure or alcohol abuse, no past medical or family history
was admitted with double vision and unsteadiness of gait. The
patient also had dizziness, left eyelid ptosis and distal
numbness on both of the upper limbs. He had antecedent
infections 5 days before the onset of the disease. He had no
fever on admission and was fully conscious without signs of
meningeal irritation. He had asymmetrical partial ptosis and
external ophthalmoplegia, and left eye was more severe than
the right eye; the light reﬂex of the pupils was well maintained.
Examination of other cranial nerves showed no positive
ﬁndings. The patient showed no weakness of all the limbs,
but all tendon reﬂexes were absent. No pathological reﬂexes
were found. Finger-to-nose and heel-to-knee tests in bothed Hospital of College of Medicine, Zhejiang University, Hangzhou
p. z o.o. All rights reserved.
Fig. 1 – T2 weighted MRI on day 6 shows multiple lesions in the juxtacortex, subcortex and deep white matter in the left
frontal and occipital lobe (A and B), and T1 weighted MRI shows cavity formation on day 360 (C).
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Pinprick sensation was impaired on the distal part of both
of the upper limbs. Cardiovascular, respiratory, gastrointesti-
nal, and ear, nose and throat ﬁndings were normal. There were
no ticks found on the skin, and no rash.
Biochemical, hematological, liver and renal function
investigations were normal. Serological tests for syphilis
and HIV were negative. Concentrations of gammaglobulin
and complement were normal, auto-antibody screen and
rheumatoid factor were negative. Chest radiography and ECG
showed no abnormality. Lumber puncture showed that
pressure was 200 mmH2O, and CSF contained 10 lympho-
cytes/mm3 and 0.26 g/l protein (on day 7). On day 6, brain MRI
showed multiple lesions in the juxtacortex, subcortex
and deep white matter in the left frontal and occipital lobe
(Fig. 1A and B). The signals were hypointensive in T1-weighted
images and isointensive in DWI images (not shown). The
lesions were not enhanced after contrast administration (notshown). The cerebellum and brainstem were not involved.
Brain CT angiography and Orbital CT scan were normal (not
shown). Electromyography of limb muscles was normal.
Neurophysiological examination showed tibial H reﬂexes
were absent. However, the motor and sensory nerve conduc-
tion velocity in ulnar, median, tibial, peroneal and sural nerves
was normal, and distal motor latencies were normal. Intrave-
nous immunoglobulin (IVIg) (0.4 g/kg per day for 5 days) was
started on day 5. Tendon reﬂexes re-appeared and pinprick
sensations of upper limbs were normal on day 18, and gradual
improvement in ataxia and ocular movement ensued in the
following 2 weeks until the time when recovery was complete
(day 60). On day 18, lumber puncture showed that the pressure
was 195 mmH2O, the CSF contained 0.58 g/l protein and
14 lymphocytes/mm3. Brain MRI of day 180 and day 360 were
similar to that of day 6, but cavity formation in the involved
matter could be found in brain MRI of day 360 (Fig. 1C). No
recurrence was seen in one-year follow up.
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MFS which is characterized by the classical triad of ataxia,
ophthalmoplegia and areﬂexia described by Fisher in 1956 is
now considered as a clinical variant of GBS [1]. MFS is an acute
postinfectious paralytic illness [1]. In our case, the antecedent
infections, the classical triad of symptoms, symmetrical
impaired superﬁcial sensation on distal part of limbs, elevated
CSF protein concentration, absent H reﬂexes and clinical
course support the diagnosis of MFS.
Several reports consider that MFS can involve both
peripheral nervous system (PNS) and CNS [2,4]. The brainstem
and cerebellum are the most common CNS sites involved in
the MFS [1]. Some reports described MFS could involve optic
nerves [3], one MFS case reported the involvement of
spinocerebellar tracts [5]. Ito et al. [6] reported a large series
of Bickerstaff's brainstem encephalitis and MFS which con-
tains 466 MFS patients. In this series, only 1% of 353 MFS
patients have abnormal CNS ﬁndings in MRI, and the abnormal
CNS lesions only include midbrain, cerebellum, or middle
cerebellar peduncle. To the best of our knowledge, only one
MFS case reported involvement of cerebral white matter [7]. In
this report, only one small lesion on each side of the cerebral
matter was found, and the brainstem was also involved. In our
case, we found that the lesions in cerebral white matter were
multiple, unilateral and extensive. The involved sites include
juxtacortex, subcortex and deep white matter. The brainstem
and cerebellum are not involved. These ﬁndings are not
reported before in MFS case. The previously reported GBS
patients with CNS involvement usually had CNS symptoms,
such as reduced consciousness level or seizure [8,9]. However,
the CNS clinical manifestations in our case were not obvious
although CNS involvement in MRI is extensive, which
indicates that an association of CNS involvement in MFS
patients may be underestimated because some lesions can be
clinically silent.
There are some possible explanations for the CNS lesions in
our patient. White matter demyelination is possible. The CNS
and PNS may share some common pathogenic epitopes [10,11].
Animal studies showed that peripheral nerve antigen could
induce CNS lesions [12], and PNS lesions could be induced in
experimental allergic encephalitis [13]. Okumura et al. also
observed demyelinated lesions in subcortex and deep white
matter in a GBS patient [14]. In MFS, serum anti-GQ1b antibody
was positive in about 85% of patients [15]. Apart from anti-GQ1b,
other antibodies associated with development of MFS include
anti-GT1a, anti-LM1, anti-GD3, anti-GM1b, GD1b, GalNAc-GD1a,
GD1b, etc. [1,16,17]. Maybe there are other uncommon anti-
bodies associated with development of MFS to be discovered.
Some of these uncommon antibodies may induce subcortex and
deep white matter lesions in MFS. Echaniz-Laguna et al. [7]
found bilateral cerebral white matter lesions in brain MRI in a
MFS patient, but the search for anti-ganglioside antibodies
(including GQ1b, GT1a/b, GM1/2/3, GD1a/b, etc.) was negative.
Even in the absence of demyelination, CNS involvement in MFS
is possible. Maier et al. [18] researched the CNS pathology in GBS
patients, and found perivascular cufﬁng of lymphocytes and
microglial activation in CNS. Patients with reversible posterior
leukoencephalopathy often have visual disturbance, loss ofconsciousness and seizures, and this syndrome is often with a
condition in which blood pressure rises sharply. Our patient did
not have hypertension and CNS symptoms, MRI lesions were
unilateral. It seems like reversible posterior leukoencephalo-
pathy is unlikely in our case.
MFS is one part of anti-GQ1b antibody syndrome which is in
fact a spectrum of disease because of their common clinical
and immunological proﬁles. Anti-GQ1b antibody syndrome
includes MFS–Bickerstaff brainstem encephalitis (BBE) syn-
drome (including MFS and BBE), pharyngeal–cervical–brachial
weakness (PCB), MFS–BBE syndrome overlapped by PCB, and
MFS–BBE syndrome overlapped by GBS. MFS also includes
some incomplete forms, such as acute ophthalmoparesis,
acute ptosis, acute mydriasis, etc. The lipo-oligosaccharides of
the bacteria (such as Campylobacter jejuni) isolated from MFS or
BBE patient were proved to mimic GQ1b, so patients with
certain immunogenetic backgrounds infected with C. jejuni
strains will produce anti-GQ1b antibodies. GQ1b is highly
expressed at oculomotor, trochlear, abducens nerves, glosso-
pharngeal and vagal nerves, group Ia afferents in muscle
spindles. Binding of anti-GQ1b antibody at these sites could
explain most of the symptoms of anti-GQ1b antibody
syndrome [19].
The demyelinated lesions in central nervous system could
persistently exist. For example, in multiple sclerosis (MS), the
demyelinated lesions will present as a new white spot on
proton density/T2-weighted MRI after the acute phase.
Variable myelin and axon injury exists in inﬂammatory
demyelinating disease of CNS (such as MS). However, the
environment in CNS is unfavorable for the regrowth of axons
and the axons cannot be remyelinated completely [20]. The
subsequent axon degeneration and gliotic process results in
scar formation and presents as a T1-black hole or a T2-bright
spot [21]. Andoni Echaniz-Laguna et al. [7] also reported that
the abnormal lesions in white matter in a MFS case had only
partially regressed 160 days later after the onset. For the
demyelinating diseases of PNS (such as GBS), the axons are
relatively preserved, the environment of PNS is much more
favorable than that of CNS for the regrowth of axons and
remyelination of axons, and myelin cells of PNS (Schwann
cells) can remyelinate the axons completely [22]. So it is not
surprising that in our case, the peripheral symptoms resolved
completely after treatment, but the lesions in the white matter
still existed one year after the onset of the disease.
In the second lumbar puncture in our case, mild pleocytosis
could be observed. This pleocytosis may be attributable to the
use of immunoglobulin. Aseptic meningitis is one of the
common complications of intravenous immunoglobulin in-
jection. However, there is no headache and meningeal
irritation sign for this patient. In MFS itself, the CSF pleocytosis
is also possible. A clinico-pathological research in a fulminant
GBS case shows that on day 1 CSF contained 100 leukocytes/
mm3. A repeated CSF examination in the same case showed
10 leukocytes/mm3 12 days later [23]. Another clinico-patho-
logical investigation of 5 GBS cases also showed a CSF cell
count of more than 50/ul in two cases and a signiﬁcant
proportion of polymorphonuclear granulocytes in the CSF
sediment in three cases [24]. Ito et al. [6] reported a large series
which contains 466 MFS patients. In this series, CSF pleocy-
tosis could be observed in about 4% MFS patients, and the cell
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inﬂammation of nerve roots may lead to an increased CSF
cell count or a proportion of polymorphonuclear granulocytes,
and the CSF pleocytosis may not exclude the diagnosis of GBS
or MFS. CSF pleocytosis is also seen in demyelinating CNS
disorders such as multiple sclerosis. In our case, the
inﬂammation of nerve roots or the leakage of blood–brain
barrier may cause the mild pleocytosis in CSF.
Our case shows the involvement of cerebral white matter in
MFS, which further indicates that MFS can affect not only
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